EV/FCF Ratio: 23.01x
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 23.01x is 50% below its 5-year average of 45.63x, near the low end of its 5-year range (21.87x–70.47x).
As of Friday, June 26, 2026. 16.97% below its 12-month average of 27.71x.
STE EV/FCF Ratio Chart
STE Average EV/FCF Ratio Chart
STE Current vs Average EV/FCF Ratio Chart
STE EV/FCF Ratio Metrics
EV/FCF RATIO
23.01x
EV/FCF RATIO AVG TTM
27.71x
EV/FCF RATIO AVG 3Y
37.52x
EV/FCF RATIO AVG 5Y
45.63x
EV/FCF RATIO AVG 10Y
40.56x
EV/FCF RATIO AVG 15Y
37.13x
EV/FCF RATIO AVG 20Y
33.23x
CURRENT VS TTM AVG
-16.97%
CURRENT VS 3Y AVG
-38.67%
CURRENT VS 5Y AVG
-49.57%
CURRENT VS 10Y AVG
-43.27%
CURRENT VS 15Y AVG
-38.03%
CURRENT VS 20Y AVG
-30.75%
STE Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $20.52B | 23.01x | 27.71x | 37.52x | 45.63x |
| Incyte Corporation (INCY)vs › | $21.48B | 12.97x | 16.50x | 96.69x | 65.85x |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 20.47x | 22.24x | 25.43x | 20.46x |
| Viatris Inc. (VTRS)vs › | $18.71B | 18.38x | 16.45x | 15.15x | 15.39x |
| BioNTech SE (BNTX)vs › | $22.76B | 7.77x | 20.16x | 6.34x | 11.23x |
| Quest Diagnostics Incorporated (DGX)vs › | $22.83B | 22.39x | 20.94x | 23.85x | 19.68x |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 24.17x | 19.20x | 17.05x | 17.05x |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.60B | 13.54x | 15.98x | 23.08x | 24.74x |
| Moderna, Inc. (MRNA)vs › | $23.71B | N/A | 26.90x | 26.23x | 26.23x |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.53x | 16.94x | 18.67x | 15.16x |
Cash Flow Valuation Comparison
EV/FCF
23.0x
P/FCF
21.3x
FCF Yield
4.69%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/FCF Ratio FAQ
- What is the EV/FCF ratio for STERIS plc (STE)?
- The EV/FCF ratio for STE stock is 23.01x.
- Is STERIS plc's EV/FCF ratio high or low?
- The EV/FCF ratio of 23.01x is 50% below its 5-year average of 45.63x, near the low end of its 5-year range (21.87x–70.47x).
- What is the TTM average EV/FCF ratio for STERIS plc (STE)?
- The TTM average EV/FCF ratio for STE stock is 27.71x.
- What is the 3Y average EV/FCF ratio for STERIS plc (STE)?
- The 3Y average EV/FCF ratio for STE stock is 37.52x.
- What is the 5Y average EV/FCF ratio for STERIS plc (STE)?
- The 5Y average EV/FCF ratio for STE stock is 45.63x.
- What is the 10Y average EV/FCF ratio for STERIS plc (STE)?
- The 10Y average EV/FCF ratio for STE stock is 40.56x.
- What is the 15Y average EV/FCF ratio for STERIS plc (STE)?
- The 15Y average EV/FCF ratio for STE stock is 37.13x.
- What is the 20Y average EV/FCF ratio for STERIS plc (STE)?
- The 20Y average EV/FCF ratio for STE stock is 33.23x.
STE EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-25 | 23.01x |
| 2026-06-24 | 22.66x |
| 2026-06-23 | 22.26x |
| 2026-06-22 | 21.97x |
| 2026-06-18 | 22.20x |
| 2026-06-17 | 21.87x |
| 2026-06-16 | 22.59x |
| 2026-06-15 | 22.53x |
| 2026-06-12 | 22.70x |
| 2026-06-11 | 22.66x |
| 2026-06-10 | 22.75x |
| 2026-06-09 | 23.24x |
| 2026-06-08 | 22.95x |
| 2026-06-05 | 23.18x |
| 2026-06-04 | 23.17x |
| 2026-06-03 | 22.96x |
| 2026-06-02 | 22.92x |
| 2026-06-01 | 23.05x |
| 2026-05-29 | 23.22x |
| 2026-05-28 | 24.98x |
| 2026-05-27 | 24.71x |
| 2026-05-26 | 25.08x |
| 2026-05-22 | 25.11x |
| 2026-05-21 | 25.44x |
| 2026-05-20 | 25.04x |
| 2026-05-19 | 24.88x |
| 2026-05-18 | 24.71x |
| 2026-05-15 | 24.63x |
| 2026-05-14 | 25.05x |
| 2026-05-13 | 24.52x |
| 2026-05-12 | 24.49x |
| 2026-05-11 | 23.52x |
| 2026-05-08 | 24.13x |
| 2026-05-07 | 24.80x |
| 2026-05-06 | 24.89x |
| 2026-05-05 | 24.72x |
| 2026-05-04 | 24.64x |
| 2026-05-01 | 24.87x |
| 2026-04-30 | 25.14x |
| 2026-04-29 | 24.69x |
| 2026-04-28 | 25.45x |
| 2026-04-27 | 25.71x |
| 2026-04-24 | 25.67x |
| 2026-04-23 | 25.86x |
| 2026-04-22 | 25.86x |
| 2026-04-21 | 25.42x |
| 2026-04-20 | 26.17x |
| 2026-04-17 | 26.10x |
| 2026-04-16 | 25.48x |
| 2026-04-15 | 25.64x |
| 2026-04-14 | 26.00x |
| 2026-04-13 | 26.00x |
| 2026-04-10 | 25.76x |
| 2026-04-09 | 25.88x |
| 2026-04-08 | 26.02x |
| 2026-04-07 | 25.39x |
| 2026-04-06 | 25.48x |
| 2026-04-02 | 25.34x |
| 2026-04-01 | 25.47x |
| 2026-03-31 | 25.60x |
| 2026-03-30 | 25.41x |
| 2026-03-27 | 25.41x |
| 2026-03-26 | 25.85x |
| 2026-03-25 | 25.84x |
| 2026-03-24 | 25.66x |
| 2026-03-23 | 25.59x |
| 2026-03-20 | 25.48x |
| 2026-03-19 | 25.25x |
| 2026-03-18 | 25.07x |
| 2026-03-17 | 25.49x |
| 2026-03-16 | 25.38x |
| 2026-03-13 | 24.89x |
| 2026-03-12 | 24.65x |
| 2026-03-11 | 25.65x |
| 2026-03-10 | 25.70x |
| 2026-03-09 | 26.31x |
| 2026-03-06 | 26.61x |
| 2026-03-05 | 27.47x |
| 2026-03-04 | 27.96x |
| 2026-03-03 | 27.99x |
| 2026-03-02 | 28.47x |
| 2026-02-27 | 28.96x |
| 2026-02-26 | 29.22x |
| 2026-02-25 | 28.88x |
| 2026-02-24 | 28.36x |
| 2026-02-23 | 28.40x |
| 2026-02-20 | 28.78x |
| 2026-02-19 | 28.84x |
| 2026-02-18 | 28.64x |
| 2026-02-17 | 28.22x |
| 2026-02-13 | 28.53x |
| 2026-02-12 | 28.09x |
| 2026-02-11 | 28.01x |
| 2026-02-10 | 28.14x |
| 2026-02-09 | 28.21x |
| 2026-02-06 | 28.94x |
| 2026-02-05 | 26.87x |
| 2026-02-04 | 28.97x |
| 2026-02-03 | 28.71x |
| 2026-02-02 | 28.97x |
| 2026-01-30 | 28.80x |
| 2026-01-29 | 28.70x |
| 2026-01-28 | 28.62x |
| 2026-01-27 | 28.85x |
| 2026-01-26 | 28.86x |
| 2026-01-23 | 28.49x |
| 2026-01-22 | 28.63x |
| 2026-01-21 | 28.66x |
| 2026-01-20 | 28.33x |
| 2026-01-16 | 29.42x |
| 2026-01-15 | 29.38x |
| 2026-01-14 | 28.97x |
| 2026-01-13 | 28.52x |
| 2026-01-12 | 28.61x |
| 2026-01-09 | 28.21x |
| 2026-01-08 | 28.60x |
| 2026-01-07 | 28.45x |
| 2026-01-06 | 28.54x |
| 2026-01-05 | 28.20x |
| 2026-01-02 | 27.51x |
| 2025-12-31 | 27.87x |
| 2025-12-30 | 28.07x |
| 2025-12-29 | 28.15x |
| 2025-12-26 | 28.06x |
| 2025-12-24 | 28.09x |
| 2025-12-23 | 28.06x |
| 2025-12-22 | 28.03x |
| 2025-12-19 | 27.95x |
| 2025-12-18 | 27.67x |
| 2025-12-17 | 27.68x |
| 2025-12-16 | 27.82x |
| 2025-12-15 | 27.92x |
| 2025-12-12 | 27.69x |
| 2025-12-11 | 27.76x |
| 2025-12-10 | 28.42x |
| 2025-12-09 | 28.25x |
| 2025-12-08 | 28.68x |
| 2025-12-05 | 28.87x |
| 2025-12-04 | 28.64x |
| 2025-12-03 | 28.47x |
| 2025-12-02 | 28.46x |
| 2025-12-01 | 28.83x |
| 2025-11-28 | 29.18x |
| 2025-11-26 | 29.24x |
| 2025-11-25 | 29.34x |
| 2025-11-24 | 28.85x |
| 2025-11-21 | 28.87x |
| 2025-11-20 | 28.22x |
| 2025-11-19 | 27.99x |
| 2025-11-18 | 28.23x |
| 2025-11-17 | 28.23x |
| 2025-11-14 | 28.37x |
| 2025-11-13 | 28.58x |
| 2025-11-12 | 29.36x |
| 2025-11-11 | 29.22x |
| 2025-11-10 | 28.95x |
| 2025-11-07 | 28.92x |
| 2025-11-06 | 28.54x |
| 2025-11-05 | 28.41x |
| 2025-11-04 | 28.26x |
| 2025-11-03 | 27.77x |
| 2025-10-31 | 27.59x |
| 2025-10-30 | 27.65x |
| 2025-10-29 | 27.71x |
| 2025-10-28 | 28.19x |
| 2025-10-27 | 28.16x |
| 2025-10-24 | 28.14x |
| 2025-10-23 | 28.26x |
| 2025-10-22 | 28.32x |
| 2025-10-21 | 28.28x |
| 2025-10-20 | 28.30x |
| 2025-10-17 | 28.08x |
| 2025-10-16 | 28.09x |
| 2025-10-15 | 27.71x |
| 2025-10-14 | 27.82x |
| 2025-10-13 | 27.57x |
| 2025-10-10 | 27.61x |
| 2025-10-09 | 28.00x |
| 2025-10-08 | 28.31x |
| 2025-10-07 | 28.23x |
| 2025-10-06 | 28.13x |
| 2025-10-03 | 28.33x |
| 2025-10-02 | 28.32x |
| 2025-10-01 | 28.20x |
| 2025-09-30 | 28.87x |
| 2025-09-29 | 28.64x |
| 2025-09-26 | 29.05x |
| 2025-09-25 | 28.52x |
| 2025-09-24 | 28.71x |
| 2025-09-23 | 29.06x |
| 2025-09-22 | 29.12x |
| 2025-09-19 | 29.01x |
| 2025-09-18 | 29.20x |
| 2025-09-17 | 29.02x |
| 2025-09-16 | 28.93x |
| 2025-09-15 | 28.91x |
| 2025-09-12 | 29.13x |
| 2025-09-11 | 29.41x |
| 2025-09-10 | 28.48x |
| 2025-09-09 | 28.97x |
| 2025-09-08 | 28.96x |
| 2025-09-05 | 28.64x |
| 2025-09-04 | 28.43x |
| 2025-09-03 | 28.33x |
| 2025-09-02 | 28.28x |
| 2025-08-29 | 28.61x |
| 2025-08-28 | 28.58x |
| 2025-08-27 | 29.04x |
| 2025-08-26 | 28.99x |
| 2025-08-25 | 28.98x |
| 2025-08-22 | 29.35x |
| 2025-08-21 | 28.88x |
| 2025-08-20 | 29.10x |
| 2025-08-19 | 28.89x |
| 2025-08-18 | 28.56x |
| 2025-08-15 | 28.66x |
| 2025-08-14 | 28.73x |
| 2025-08-13 | 28.83x |
| 2025-08-12 | 28.47x |
| 2025-08-11 | 28.24x |
| 2025-08-08 | 28.37x |
| 2025-08-07 | 27.65x |
| 2025-08-06 | 30.69x |
| 2025-08-05 | 31.03x |
| 2025-08-04 | 31.61x |
| 2025-08-01 | 31.41x |
| 2025-07-31 | 31.36x |
| 2025-07-30 | 31.71x |
| 2025-07-29 | 31.60x |
| 2025-07-28 | 31.37x |
| 2025-07-25 | 31.86x |
| 2025-07-24 | 31.46x |
| 2025-07-23 | 31.23x |
| 2025-07-22 | 31.00x |
| 2025-07-21 | 30.87x |
| 2025-07-18 | 31.24x |
| 2025-07-17 | 31.12x |
| 2025-07-16 | 31.50x |
| 2025-07-15 | 31.66x |
| 2025-07-14 | 31.27x |
| 2025-07-11 | 31.56x |
| 2025-07-10 | 31.90x |
| 2025-07-09 | 31.97x |
| 2025-07-08 | 32.13x |
| 2025-07-07 | 32.23x |
| 2025-07-03 | 32.76x |
| 2025-07-02 | 32.85x |
| 2025-07-01 | 33.41x |
| 2025-06-30 | 33.10x |
| 2025-06-27 | 32.92x |
| 2025-06-26 | 32.89x |
| 2025-06-25 | 33.12x |
| 2025-06-24 | 33.02x |
| 2025-06-23 | 32.68x |
| 2025-06-20 | 32.53x |
| 2025-06-18 | 32.60x |
| 2025-06-17 | 32.70x |
| 2025-06-16 | 33.22x |
| 2025-06-13 | 33.25x |
| 2025-06-12 | 33.38x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio